Expert Opinion on Drug Discovery

译名:药物发现专家观点

SCIEJCR Q1

5-10

2026

影响因子区间

平台估算

投稿周期

8%

2025

中国作者发文占比

3150 CHF

费用说明

收费

期刊简介:Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.The Editors welcome:Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biologyDrug Case Histories examining the steps involved in the preclinical and clinical development of a particular drugThe audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.

【译文】关于药物发现的专业意见(ISSN 1746-0441 [印刷版],1746-045X [电子版])是一本MEDLINE索引、同行评审的国际期刊,发表关于药物发现过程中涉及的新技术的综述文章,这些技术导致新的先导化合物和降低淘汰率。每篇文章的结构都旨在纳入作者对未来发展范围的自身专业意见。编辑们欢迎以下内容的综述:化学信息学;生物信息学;检测方法开发;新型筛选技术;体外/体内模型;基于结构的药物设计;系统生物学;药物案例历史,探讨特定药物在临床前和临床开发过程中涉及的步骤。读者包括医疗保健和制药行业的科学家和管理人员、学术药物科学家以及其他相关专业人士,他们希望通过临床前水平的优化来提高其药物候选人的成功率。

出版社
Taylor & Francis
语言
English
学科
医学
ISSN
1746-0441
eISSN
1746-045X
出版频率
双月刊
创刊年份
2006
投稿网址
https://mc.manuscriptcentral.com/eodc
最近更新
2026-04-02 18:16:40
Expert Opinion on Drug Discovery

指标当前值近三年趋势
JCR分区Q1
暂无
影响因子区间5-10
暂无